Yahoo Web Search

  1. Ad

    related to: Australian Pharmaceutical Industries
  2. Clinical-grade Active Pharmaceutical Ingredient apo for clinical research. Clinical-grade Active Pharmaceutical Ingredient API for clinical research.

    • Our Team

      We are a Canadian biotechnology

      company dedicated to the ...

    • Products

      Find Out What You Need to Know

      About Our Products.

Search results

  1. www.api.net.au. Australian Pharmaceutical Industriea (API) is a health and beauty company owned by Wesfarmers. It is involved in pharmaceutical distribution, retailing and manufacturing. API is Australia's largest wholesale distributor of pharmaceutical and allied products. [1]

  2. Australia’s multi-billion-dollar pharmaceutical market has been growing steadily over the past decade and appears to have maintained this growth despite challenges brought on by the...

  3. 253. Australian Pharmaceutical Industries (API) | 17,009 followers on LinkedIn. Australian Pharmaceutical Industries Limited (API) is one of Australia’s leading pharmaceutical...

  4. www.wesfarmers.com.au › our-businesses › wesfarmersWesfarmers Health

    Australian Pharmaceutical Industries. Since its beginnings in 1910, API has grown from a small co-operative of three pharmacies to now one of Australia’s leading health, beauty and wellbeing companies.

  5. www.wesfarmers.com.au › investor-centre › yourAPI Acquisition - Wesfarmers

    Mar 31, 2022 · Wesfarmers acquired Australian Pharmaceutical Industries Limited (API) on 31 March 2022 by way of a scheme of arrangement. As a result, API shares were suspended from close of trading on the ASX on 22 March 2022 and it was delisted from the ASX on 1 April 2022.

  6. Jan 7, 2022 · Jan 7 (Reuters) - Australian Pharmaceutical Industries (API.AX) said on Friday conglomerate Wesfarmers Ltd would buy it for A$763.6 million ($546.9 million) after Woolworths pulled out of a...

  7. Transaction details. Wesfarmers today announced that it has submitted a non-binding, indicative offer to acquire 100 per cent of the shares outstanding in API for $1.38 cash per share by way of a scheme of arrangement. 1.

  1. Ad

    related to: Australian Pharmaceutical Industries
  2. Clinical-grade Active Pharmaceutical Ingredient apo for clinical research. Clinical-grade Active Pharmaceutical Ingredient API for clinical research.

  1. People also search for